NYSE$USPH

US Physical Therapy Inc · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Second quarter results reported with revenue increase, but net income and operating income decreased compared to the same period last year.

U.S. Physical Therapy reported a 10.8% increase in total revenue to $140.7 million for the second quarter of 2022, driven by growth in physical therapy operations and industrial injury prevention services. However, net income attributable to USPH shareholders decreased to $11.2 million, and operating income also saw a decrease.

  • Operating Results per diluted share was $0.90, the second highest quarterly amount in the Company’s history.
  • Adjusted EBITDA was $21.3 million.
  • Net income attributable to shareholders was $11.2 million.
  • Total revenue was $140.7 million, an increase of 10.8%.

Headline financials

Total Revenue

$141M

Previous: $127M+10.8%
EPS (adj)

$0.90

Previous: $0.96-6.2%
Total Patient Visits

1.1M

No prior period
Net Rate per Visit

$103.18

Previous: $104.46-1.2%
Free Cash Flow

$11.2M

Previous: $12.4M-10.0%
Net Income

$11.2M

Previous: $12.4M-10.0%
Operating Income

$20.1M

Previous: $22.2M-9.7%
Gross Profit

$30.8M

Previous: $34.3M-10.2%
Cash & Equivalents

$48.6M

Previous: $20.4M+137.9%
Total Assets

$796M

Previous: $623M+27.8%
Stock-Based Comp

$1.81M

Previous: $1.75M+3.4%

Revenue & EPS history

US Physical Therapy · Revenue · Quarterly

$141M

Q2 2022+10.8%vs Q2 2021
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

US Physical Therapy · $119M total across 1 segment · Q2 2022

  • Physical Therapy Operations
    $119M

Forward guidance

Management expects Adjusted EBITDA for the full year of 2022 to be in the range of $73.5 million to $75.4 million and Operating Results to be in the range of $2.65 to $2.75 per share.

Tailwinds

  • Company has $150 million of fixed debt which is currently expected to generate interest at a fixed rate of 4.665% for the remainder of the year.
  • New credit facility gives more dry powder to use for acquisitions and other investments.
  • Expect to close a number of deals before year’s end which should be very positive for 2023 and forward.
  • Financing transaction completed in the second quarter, which was important to provide the capital needed for growth.
  • Interest rate swap, which fixed the interest rate on $150 million of our debt for five years, provides certainty in the rising interest rate environment at a rate that we believe is favorable over the five-year period.

Headwinds

  • Increases in the Company’s interest expense due to rising interest rates in the U.S.
  • Impact of inflation on the Company’s wages and other costs which elevated during the second quarter and are expected to continue through the remainder of the year.
  • Increasingly difficult operating environment
  • Rising costs
  • Costs will be higher than originally expected for the remainder of the year

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

-0.6%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-1.3%

Avg return

30 days after

53%

35 / 66 earnings

Positive

+17.3%

Q3 2024

Best reaction

-27.5%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.5%+1.3%+7.5%
Q4 2025-2.9%+1.9%-8.5%
Q3 2025+0.9%-15.8%-13.8%
Q2 2025+14.7%+20.4%+17.8%
Q1 2025-0.1%+8.8%+8.9%
Q4 2024-6.0%-9.5%-18.0%
Q3 2024+17.3%+14.8%+17.9%
Q2 2024-6.8%-3.9%-5.4%
Q1 2024-2.2%+0.2%-8.0%
Q4 2023+3.4%+2.8%+9.8%
Q3 2023-2.8%-3.3%+4.3%
Q2 2023-8.6%-8.1%-19.8%
Q1 2023+4.5%+10.1%+2.1%
Q4 2022+2.1%+2.2%-5.7%
Q3 2022-8.9%-4.0%-0.3%
Q2 2022-27.5%-29.9%-37.0%
Q1 2022-4.4%-4.1%+4.2%
Q4 2021-5.8%-6.5%-2.1%
Q3 2021-3.6%-8.2%-21.6%
Q2 2021-3.6%-5.4%-1.1%
Q1 2021+6.0%+4.5%+6.6%
Q4 2020-17.2%-19.8%-24.3%
Q3 2020+8.4%+26.6%+29.2%
Q2 2020+2.4%+1.1%+3.7%
Q1 2020-1.0%+2.7%+0.9%
Q4 2019-17.7%-16.0%-49.0%
Q3 2019-20.1%-20.4%-20.5%
Q2 2019+3.9%+6.1%+8.1%
Q1 2019+2.3%+3.3%-1.2%
Q4 2018+3.2%+3.4%+2.1%
Q3 2018+5.1%+6.5%+10.7%
Q2 2018+8.9%+7.0%+18.9%
Q1 2018-1.4%-0.5%+2.4%
Q4 2017+6.8%+2.7%+4.9%
Q3 2017-2.6%-2.9%+5.7%
Q2 2017+2.4%+2.6%-2.9%
Q1 2017-6.0%+0.8%-2.1%
Q4 2016+1.7%+2.0%-1.2%
Q3 2016-1.2%+0.5%+14.3%
Q2 2016+4.7%+4.0%+9.7%
Q1 2016+12.7%
Q4 2015+1.2%
Q3 2015+2.3%
Q2 2015-5.0%
Q1 2015+7.9%
Q4 2014+5.4%
Q3 2014-7.2%
Q2 2014+5.8%
Q1 2014+3.0%
Q4 2013-0.3%
Q3 2013-7.1%
Q2 2013+6.0%
Q1 2013+3.5%
Q4 2012-4.6%
Q3 2012+0.6%
Q2 2012+0.6%
Q1 2011+1.0%
Q1 2012+2.1%
Q4 2009-0.2%
Q4 2011-0.2%
Q3 2011+1.9%
Q3 2010+1.9%
Q2 2010-10.9%
Q2 2011-10.9%
Q4 2010-10.9%
Q1 2010+12.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro